Affimed Therapeutics AG, the therapeutic TandAb antibody company, today announced the successful closing of a Series D financing round of € 15.5 million. The proceeds from this transaction will be used to fund the clinical...
Agennix AG (Frankfurt Stock Exchange: AGX) today announced a restructuring that involves staff reductions of approximately 55 percent of the Company’s workforce. The restructuring is being implemented to conserve cash as...
SYGNIS Pharma AG (Frankfurt: LIOK; ISIN DE000A1E9B74; Prime Standard) today reports its financial results for the first quarter of the fiscal year 2012/2013 ended June 30, 2012
Imprint 
Contact Us 
